Aspen Pharmacare wins Canada approval for generic Ozempic injection

South African pharma giant secures Canadian nod for generic Ozempic

A Canadian subsidiary of Africa’s largest pharmaceutical company has officially received regulatory approval from Health Canada to distribute a generic version of a highly popular type 2 diabetes and weight-loss blockbuster drug. Durban-based Aspen Pharmacare was granted authorisation for Aspen-Semaglutide, an generic alternative to Novo Nordisk’s Ozempic, following the expiration of the original patent in January 2026. Aspen’s ‘Ozempic’ on the …

Aspen Pharmacare wins Canada approval for generic Ozempic injection

JOHANNESBURG, July 20 (Reuters) - South Africa's ​Aspen ‌Pharmacare said on Monday that its ‌Canadian ​subsidiary ⁠had received ⁠regulatory approval from Health Canada for ​Aspen-Semaglutide, a ⁠generic ⁠semaglutide injectable ​used to ​treat adults wi...